These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 10442567

  • 1. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
    Alford FP, Hew FL, Christopher MC, Rantzau C.
    J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
    [Abstract] [Full Text] [Related]

  • 2. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M, Hew FL, Oakley M, Rantzau C, Alford F.
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [Abstract] [Full Text] [Related]

  • 3. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H.
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [Abstract] [Full Text] [Related]

  • 4. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [Abstract] [Full Text] [Related]

  • 5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 6. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC, Dunger DB.
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [Abstract] [Full Text] [Related]

  • 7. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC, Conceição FL, Soares DV, Spina LD, Brasil RR, Lobo PM, Michmacher E, Vaisman M.
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC, Dunger DB.
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [Abstract] [Full Text] [Related]

  • 9. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.
    Bak JF.
    Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433
    [Abstract] [Full Text] [Related]

  • 10. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 11. Effect of 12 months of recombinant human growth hormone replacement therapy on insulin sensitivity in GH-deficient adults as determined by different methods.
    Micic D, Cvijovic G, Doknic M, Kendereski A, Popovic V.
    J Postgrad Med; 2002 May; 48(4):260-5; discussion 265. PubMed ID: 12571379
    [Abstract] [Full Text] [Related]

  • 12. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
    Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER.
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [Abstract] [Full Text] [Related]

  • 14. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
    Attallah H, Friedlander AL, Hoffman AR.
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
    [Abstract] [Full Text] [Related]

  • 15. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C, Cappiello V, Corbetta S, Ronchi CL, Morpurgo PS, Ferrante E, Beck-Peccoz P, Spada A.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 17. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
    Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ, Lambeth H.
    Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
    [Abstract] [Full Text] [Related]

  • 19. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J.
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
    Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.